Abstract
Expression of recombinant herpes simplex virus type 1 (HSV-1) deoxyribonuclease (DNase) was analyzed in BHK-21 cells, a standard cell line for virus propagation, by using mammalian cell expression systems based on vaccinia virus and on Semliki Forest virus (SFV)1. Although the establishing of recombinant vaccinia virus failed due to the apparent toxicity of the herpesviral enzyme, soluble and functional HSV-1 DNase was efficiently expressed in BHK-21 cells by the vaccinia virus/T7 RNA polymerase hybrid system as well as by recombinant Semliki Forest virus. Using rabbit antiserum ExoC, directed against the C-terminal residues 503–626, or mouse monoclonal antibody (MAb) Q1, raised against the type 2 enzyme, a major 85-kDa protein with the identical size of the enzyme from HSV-1-infected cells was identified to be induced in both expression systems. With recombinant SFV functional HSV-1 DNase coincided with the overproduction of a single major 85-kDa protein re aching an optimum between 16 h and 36 h after infection. At later times of infection the enzymatic activity vanished. Thus, recombinant SFV may be an appropriate expression vector for biochemical studies of the enzyme when (i) packaged recombinant virus particles are used for infection and (ii) infection does not exceed 24 h. Due to the limitations of transient expression systems, the vaccinia/T7 RNA polymerase hybrid system is suited for expression analysis on a small scale, and for studying intracellular interactions of the enzyme as demonstrated by immunofluorescence microscopy studies. Using vector pTM1, recombinant HSV-1 DNase was efficiently overproduced in BHK-21 cells at 6 h after transfection and was shown to colocalize with the cellular chromatin at sites apparently distinct from the bulk of the herpesviral replication sites the way it is observed for the enzyme of lytically infected cells. The deleting of the 123 C-terminal amino acid residues did not alter this nuclear loca lization of HSV-1 DNase, suggesting that the latter sequences and other herpesviral factors are not required for the chromatin association.
Similar content being viewed by others
References
Draper K.G., Devi-Rao G., Costa R.H., Blair E.D., Thompson R.L., and Wagner E.K., J Virol 57, 1023-1036, 1986.
Costa R.H., Draper K.G., Banks L., Powell K.L., Cohen G., Eisenberg R., and Wagner E.K., J Virol 48, 591-603, 1983.
McGeoch D.J., Dolan A., and Frame M.C., Nucl Acids Res 14, 3435-3448, 1986.
Martinez R., Shao L., Bronstein J.C., Weber P.C., and Weller S.K., Virology 215, 152-164, 1996.
Banks L., Purifoy D.J.M., Hurst P.-F., Killington R.A., and Powell K.L., J Gen Virol 64, 2249-2260, 1983.
Banks L.M., Halliburton I.W., Purifoy D.J.M., Killington R.A., and Powell K.L., J Gen Virol 66, 1-14, 1985.
Keir H.M. and Gold E., Biochim Biophys Acta 72, 263-276, 1963.
Hoffmann P.J. and Cheng Y.-C., J Biol Chem 253, 3557-3562, 1978.
Hoffmann P.J. and Cheng Y.-C., J Virol 32, 449-457, 1979.
Hoffmann P.J., J. Virol 38, 1005-1014, 1981.
Knopf C.W. and Weisshart K., Eur J Biochem 191, 263-273, 1990.
Kehm E., Göksu M.-A., Bayer S., and Knopf C.W., Intervirology, submitted, 1998.
Fraser M.J., Hatahet Z., and Huang X., J Biol Chem 264, 13093-13101, 1989.
Fraser M.J., Bioessays 16, 761-766, 1994.
Weller S.K., Seghatoleslami M.R., Shao L., Rowse D., and Carmicheal E.P., J Gen Virol 71, 2941-2952, 1990.
Shao L., Rapp L.M., and Weller S.K., Virology 196, 146-162, 1993.
Martinez R., Sarisky R.T., Weber P.C., and Weller S.K., J Virol 70, 2975-2085, 1996.
Strick R., Hansen J., Bracht R., Komitowski D., and Knopf C.W., Intervirology 40, 41-49, 1997.
Fuerst T.R., Niles E.G., Studier F.W., and Moss B., Proc Natl Acad Sci USA 83, 8122-8126, 1986.
Falkner F.G. and Moss B., J Virol 62, 1849-1854, 1988.
Moss B., Elroy-Stein O., Mizukami T., Alexander W.A., and Fuerst T.R., Nature 348, 91-92, 1990.
Strebel K., Beck E., Strohmaier K., and Schaller H., J Virol 57, 983-991, 1986.
Laemmli U.K., Nature 227, 680-685, 1970.
Weisshart K. and Knopf C.W., Eur J Biochem 174, 707-716, 1988.
Kühn F.J.P. and Knopf C.W., J Biol Chem 271, 29245-29254, 1996.
Elroy-Stein O. and Moss B., in: “Current Protocols in Molecular Biology”, Eds Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K., John Wiley & Sons, Inc., vol. 2, 16.19.1-16.19.9, 1992.
Liljeström P. and Garoff H., Bio/Technology 9, 1356-1361, 1991.
Garnier J., Osguthorpe D.J., and Robson B., J Mol Biol 120, 97-120, 1978.
Bronstein J.C. and Weber P.C., J Virol 70, 2008-2013, 1996.
Strobel-Fidler M. and Francke B., Virology 103, 493-501, 1980.
Elroy-Stein O., Fuerst T.R., and Moss B., Proc Natl Acad Sci USA 86, 6126-6130, 1989.
Randall R.E. and Dinwoodie N., J Gen Virol 67, 2163-2177, 1986.
Puvion-Dutilleul F. and Pichard E., Biology of the Cell 58, 15-22, 1986.
McGeoch D.J., Dalrymple M.A., Davison A.J., Dolan A., Frame M.C., McNab D., Perry L.J., Scott J.E., and Taylor P., J Virol 69, 1531-1574, 1988.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kehm, E., Go¨ksu, MA. & Knopf, C. Expression Analysis of Recombinant Herpes Simplex Virus Type 1 DNase. Virus Genes 17, 129–138 (1998). https://doi.org/10.1023/A:1008012606497
Issue Date:
DOI: https://doi.org/10.1023/A:1008012606497